BRIEF-Marker Therapeutics Awarded $9.5 Mln Grant From The Cancer Prevention & Research Institute Of Texas (Cprit)

Reuters12-17

BRIEF-Marker <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Awarded $9.5 Mln Grant From The Cancer Prevention & Research Institute Of Texas (Cprit)

Dec 17 (Reuters) - Marker Therapeutics Inc MRKR.O:

MARKER THERAPEUTICS AWARDED $9.5 MILLION GRANT FROM THE CANCER PREVENTION & RESEARCH INSTITUTE OF TEXAS (CPRIT) TO SUPPORT THE INVESTIGATION OF MT-601 IN PATIENTS WITH PANCREATIC CANCER
MARKER THERAPEUTICS: PLANS TO INVESTIGATE ITS POTENTIAL APPLICATION BEYOND LYMPHOMA IN PATIENTS WITH SOLID TUMORS
MARKER THERAPEUTICS INC: ANTICIPATES CLINICAL PROGRAM INITIATION IN 2025

Source text: ID:nGNX24rf9p

Further company coverage: MRKR.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492951353?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-17 20:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492951353","market":"us","top_or_hot":-1,"title":"BRIEF-Marker Therapeutics Awarded $9.5 Mln Grant From The Cancer Prevention & Research Institute Of Texas (Cprit)","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Marker <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Awarded $9.5 Mln Grant From The Cancer Prevention &amp; Research Institute Of Texas (Cprit) </title></head><body><p><span>Dec 17 (Reuters)</span><span> - </span>Marker Therapeutics Inc <span>MRKR.O</span>:</p><ul><li><p>MARKER THERAPEUTICS AWARDED $9.5 MILLION GRANT FROM THE CANCER PREVENTION &amp; RESEARCH INSTITUTE OF TEXAS (CPRIT) TO SUPPORT THE INVESTIGATION OF MT-601 IN PATIENTS WITH PANCREATIC CANCER</p></li><li><p>MARKER THERAPEUTICS: PLANS TO INVESTIGATE ITS POTENTIAL APPLICATION <a href=\"https://laohu8.com/S/BYON\">BEYOND</a> LYMPHOMA IN PATIENTS WITH SOLID TUMORS</p></li><li><p>MARKER THERAPEUTICS INC: ANTICIPATES CLINICAL PROGRAM INITIATION IN 2025</p></li></ul><p>Source text: <span>ID:nGNX24rf9p</span></p><p>Further company coverage: <span>MRKR.O</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Marker Therapeutics Awarded $9.5 Mln Grant From The Cancer Prevention & Research Institute Of Texas (Cprit)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Marker Therapeutics Awarded $9.5 Mln Grant From The Cancer Prevention & Research Institute Of Texas (Cprit)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-17 20:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nFWN3NI04O:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Marker Therapeutics Awarded $9.5 Mln Grant From The Cancer Prevention & Research Institute Of Texas (Cprit) Dec 17 (Reuters) - Marker Therapeutics Inc MRKR.O:MARKER THERAPEUTICS AWARDED $9.5 ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nFWN3NI04O:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRKR","symbol_name":"Marker Therapeutics, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nFWN3NI04O:1","article_id":"2492951353","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492951353","pubTimestamp":1734439607,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Marker Therapeutics Awarded $9.5 Mln Grant From The Cancer Prevention & Research Institute Of Texas (Cprit) Dec 17 (Reuters) - Marker Therapeutics Inc MRKR.O:MARKER THERAPEUTICS AWARDED $9.5 MIL","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRKR":"Marker Therapeutics, Inc.","BK4139":"生物科技"},"translate_title":"BRIEF-Marker Therapeutics获得德克萨斯州癌症预防与研究所(Cprit)950万美元资助","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRKR":0.9},"content_text":"BRIEF-Marker Therapeutics Awarded $9.5 Mln Grant From The Cancer Prevention & Research Institute Of Texas (Cprit) Dec 17 (Reuters) - Marker Therapeutics Inc MRKR.O:MARKER THERAPEUTICS AWARDED $9.5 MILLION GRANT FROM THE CANCER PREVENTION & RESEARCH INSTITUTE OF TEXAS (CPRIT) TO SUPPORT THE INVESTIGATION OF MT-601 IN PATIENTS WITH PANCREATIC CANCERMARKER THERAPEUTICS: PLANS TO INVESTIGATE ITS POTENTIAL APPLICATION BEYOND LYMPHOMA IN PATIENTS WITH SOLID TUMORSMARKER THERAPEUTICS INC: ANTICIPATES CLINICAL PROGRAM INITIATION IN 2025Source text: ID:nGNX24rf9pFurther company coverage: MRKR.O","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492951353"}